Oxford BioMedica Seeks £40M As It Moves To London Exchange

Gendaq Says Zinc Finger Platform Ready For Regulation Of Genes

RiboTargets Signs Deal With J&J, Plans Financing Round Of £20M

Oxford BioMedica Seeks £40M As It Moves To London Exchange

Celltech Getting $50M Up Front In $230M Pharmacia Collaboration

CellFactors Gains Broad Patent In U.S. Covering CNS Cell Lines

Government Helps London Centers Spin Off Companies

PPL Says Disease In UK Should Not Affect Clones

GlaxoSmithKline Adopts Biotech Business Model, Creates Six Units

Xenova On Track To Partner XR9576 Following Phase II